GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akums Drugs and Pharmaceuticals Ltd (BOM:544222) » Definitions » Pre-Tax Income

Akums Drugs and Pharmaceuticals (BOM:544222) Pre-Tax Income : ₹1,498 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Akums Drugs and Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Akums Drugs and Pharmaceuticals's pretax income for the three months ended in Dec. 2024 was ₹911 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was ₹1,498 Mil. Akums Drugs and Pharmaceuticals's pretax margin was 9.01%.

During the past 4 years, Akums Drugs and Pharmaceuticals's highest Pretax Margin was 6.39%. The lowest was -5.30%. And the median was 1.60%.


Akums Drugs and Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Akums Drugs and Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akums Drugs and Pharmaceuticals Pre-Tax Income Chart

Akums Drugs and Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
1,722.61 -1,931.97 1,502.97 -452.78

Akums Drugs and Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
Pre-Tax Income Get a 7-Day Free Trial 871.20 592.78 -328.83 915.86 910.53

Competitive Comparison of Akums Drugs and Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Akums Drugs and Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akums Drugs and Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akums Drugs and Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Akums Drugs and Pharmaceuticals's Pre-Tax Income falls into.


;
;

Akums Drugs and Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Akums Drugs and Pharmaceuticals's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=3598.99+0+-502.51+119.99+-3669.25
=-453

Akums Drugs and Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=768.45+0+-51.34+0+193.42
=911

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,498 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akums Drugs and Pharmaceuticals  (BOM:544222) Pre-Tax Income Explanation

Akums Drugs and Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=910.53/10104.11
=9.01%

During the past 4 years, Akums Drugs and Pharmaceuticals's highest Pretax Margin was 6.39%. The lowest was -5.30%. And the median was 1.60%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akums Drugs and Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Akums Drugs and Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Akums Drugs and Pharmaceuticals Headlines

No Headlines